Alzheimer's disease is thought to be caused by the buildup of abnormal protein deposits in the brain, but little is known about the molecular structures of these beta-amyloid fibrils. A new study has revealed that distinct molecular structures may predominate in the brains of Alzheimer's patients with different clinical histories and degrees of brain damage. The findings pave the way for new patient-specific strategies to improve diagnosis and treatment.